Aperture Sectors › Healthcare & Life Sciences › Care delivery & patient engagement
Care delivery & patient engagement funding
Care delivery & patient engagement
A sub-sector of Healthcare & Life Sciences. Each company counts once, in its main sub-sector.
291 rounds, $6.2B raised by 246 companies, Jan 2, 2023 to Nov 14, 2026, 13% of Healthcare & Life Sciences capital. Top three companies: Hippocratic AI 6%, Aledade 4%, Grow Therapy 4%.
| Company | HQ | Capital raised | Rounds | Exit |
|---|---|---|---|---|
| Hippocratic AI | United States | $387M | 5 | — |
| Aledade | United States | $260M | 1 | — |
| Grow Therapy | United States | $238M | 2 | — |
| Garner Health | United States | $218M | 2 | — |
| Talkiatry | United States | $210M | 3 | — |
| Inspiren | United States | $205M | 3 | — |
| eMed | United States | $200M | 1 | — |
| Spring Health | United States | $171M | 2 | — |
| Nourish | United States | $170M | 2 | — |
| DUOS | United States | $140M | 2 | — |
| K Health | United States | $126M | 3 | — |
| General Medicine | United States | $120M | 1 | — |
| Twin Health | United States | $103M | 2 | — |
| Sage | United States | $100M | 2 | — |
| Cadence | United States | $100M | 1 | — |
| DentalMonitoring | France | $100M | 1 | — |
| Tala Health | United States | $100M | 1 | — |
| Lumeris | United States | $100M | 1 | — |
| Slingshot AI | United States | $83M | 2 | — |
| Sensi.AI | United States | $76M | 2 | — |
| Sword Health | United States | $70M | 2 | — |
| Conceivable Life Sciences | United States | $68M | 2 | — |
| Doctronic | United States | $60M | 2 | — |
| Fabric | United States | $60M | 1 | — |
| Everlab | Australia | $58M | 3 | — |
| Company | Amount | Stage | Announced |
|---|---|---|---|
| Aledade | $260M | Series F+ | Jun 22, 2023 |
| Talkiatry | $210M | Series D | Feb 12, 2026 |
| eMed | $200M | Series A | Mar 26, 2026 |
| Grow Therapy | $150M | Series D | Mar 3, 2026 |
| Hippocratic AI | $141M | Series B | Jan 9, 2025 |
| DUOS | $130M | Growth | Oct 9, 2025 |
| Hippocratic AI | $126M | Series C | Nov 3, 2025 |
| General Medicine | $120M | Series B | Oct 6, 2026 |
| Garner Health | $118M | Series D | Feb 10, 2026 |
| Cadence | $100M | Series C | Jun 23, 2026 |